Monday, December 17, 2012

Can physicians change interest and participation in clinical trials?

Tomasz M. Beer, MD, FACP, recently weighed in on the importance of adults participating in oncology clinical trials.  At Oncology Times, he points out that only 3-5% of adults who have cancer ever participate in a clinical trial.  Why?  He believes that both physicians and patients are at fault for the low amounts of participation.

Doctors are often unaware of the right trials, fear the loss of control of the care for their patients, believe that the traditional methods of care are often better for the patients or fear the amounts of paperwork that may come with the trial.

But is this really fair to the patient?  Medicine is evolving  treatments are getting better.  There is no better example of this than with the evolving field of personalized medicine.  Specific cancers can be treated with the down to the defect and promise better, more effective treatments than traditional methods.

At Partnerships in Clinical Trials 2013, we feature an all new Patient-Centered Clinical Trials Summit.  This full day workshop will gather the heads of the industry including Jane Myles, Global Head Patient Recruitment, Genentech, Chris Zizzamia, Clinical Programs, Shire and more to discuss how to promote the awareness of clinical trials and keep patients coming back to improve the clinical trail process.  For more information on Partnerships in Clinical Trials taking place April 22-24, 2013 in Orlando, visit the webpage.  If you'd like to join us, register today and mention code XP1800BLOG and save 15% off the standard rate.

So with these kinds of clinical trials promising better treatment, how does the industry promote knowledge and awareness of clinical trials?




No comments: